A pilot study of the safety and efficacy of AST-120 in the treatment of antibiotic-refractory pouchitis.
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Charcoal (Primary)
- Indications Pouchitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Ocera Therapeutics
- 28 Oct 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Jan 2008 New trial record.